医学
认知
生活质量(医疗保健)
疾病
胆汁淤积
病理生理学
重症监护医学
物理疗法
内科学
精神科
护理部
作者
Naw April Phaw,Jessica Leighton,Jessica Dyson,David Jones
标识
DOI:10.1080/17474124.2021.1844565
摘要
Introduction: Patients with cholestatic diseases may develop fatigue and cognitive symptoms. The impact of symptom burden may be significant in some patients. To date, there are no effective pharmacological therapies to improve cognitive symptoms or fatigue in cholestasis and we are wholly reliant on supportive approaches.Area covered: This review provides an overview of cognitive symptoms and fatigue in the cholestatic liver disease primary biliary cholangitis (PBC), including pathophysiology and our approach to the management of these symptoms.Expert opinion: The impact of fatigue and cognitive symptoms on the perceived quality of life can be profound for patients with PBC. The pathophysiology of these symptoms is complex and poorly understood, making the development of therapeutic trials of symptom-directed therapies challenging. The current recommended management for fatigue and cognitive symptoms is mainly supportive.
科研通智能强力驱动
Strongly Powered by AbleSci AI